What changed
$TRV — WATCHLIST 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $11.9B | EPS $7.71 vs $7.08 🟢
💡 The market sees a low-quality beat, possibly due to one-time reserve releases or benign catastrophe losses; my variant view is that the beat reflects underlying improvement in underwriting margins, but without further catalysts, repricing may be delayed.
📉 Reward/risk: 1.25:1
🏢 Business Quality: 7/10
📊 Valuation: cheap relative to historical P/E (currently ~10.5x annualized Q1 EPS vs 5-year median ~12x) and peer group (large-cap insurers trade at 12-14x...
🔮 Catalyst: Dividend increase and earnings beat are already priced; next catalyst is Q2 earnings in October 2026, outside our horizon
💰 Entry: $320.18, stop $300.0, target $345.0
📊 Our read: WATCHLIST. Full analysis →
https://stockduty.xyz/s/TRV0624